跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Synacthen 0.25mg/1mL injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
Synacthen 0.25mg/1mL injection ampoule
Approved
STANDARD
Synacthen 0.25mg/1mL injection ampoule
Atnahs Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2a3288f5f8f070f8
Company
Atnahs Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
2a3288f5f8f070f8
Product Name
Synacthen 0.25mg/1mL injection ampoule
Artg Id
11058
Artg Name
SYNACTHEN tetracosactide (tetracosactrin) 0.25mg/1mL injection ampoule
Sponsor
Atnahs Pharma Australia Pty Ltd
Company Detail Path
/organization/atnahs-pharma-australia-pty-ltd
Artg Date
1991-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8084a9ab3ad7adcf7893cf49868b39ac.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/276330de551c9880bd2d48f0066bae08.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2a3288f5f8f070f8
Type
Standard
Back to TGA Approvals